Filing Flows › Incyte (INCY) › Recalls, complaints & regulation
Incyte (INCY): clinical trials
Incyte (INCY) beyond its filings: 61 active clinical trials.
Incyte's latest quarter
Incyte, Q3 2026: revenue $1.6B (+14% year over year), operating margin -45.5%, net loss $785M, operating cash flow −$675M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Incyte have?
61 active studies on ClinicalTrials.gov, 23 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.